4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001649904-26-000015
Chief Technical Officer sold 5,079 shares at $119.75 ($608,210)
- Chief Technical Officer acquired 2,024 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Shulman Joseph · Chief Technical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-08-13 | Exercise or conversion : show line 1 in the form 10b5-1 | +2,024 | $6.80 | $13,763 | 20,994 | D |
| 2026-08-13 | Sale : show line 2 in the form 10b5-1 | −5,079 | $119.75 | $608,210 | 15,915 | D |
| Open-market sales · 5,079 sh · avg $119.75 · $608,210 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-08-13 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Options (Right to Buy) | −2,024 | 5,945 | D |
Loading xslF345X06/form4.xml…